Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

AIMS: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasingly diagnosed disease. Echocardiography is widely utilized, but studies to confirm the value of echocardiography for tracking changes over time are not available. We sought to describe (i) changes in multiple echocardiographic param...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacko, Liza, Karia, Nina, Venneri, Lucia, Bandera, Francesco, Passo, Beatrice Dal, Buonamici, Lodovico, Lazari, Jonathan, Ioannou, Adam, Porcari, Aldostefano, Patel, Rishi, Razvi, Yousuf, Brown, James, Knight, Daniel, Martinez‐Naharro, Ana, Whelan, Carol, Quarta, Candida C., Manisty, Charlotte, Moon, James, Rowczenio, Dorota, Gilbertson, Janet A., Lachmann, Helen, Wechelakar, Ashutosh, Petrie, Aviva, Moody, William E., Steeds, Richard P., Potena, Luciano, Riefolo, Mattia, Leone, Ornella, Rapezzi, Claudio, Hawkins, Philip N., Gillmore, Julian D., Fontana, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Cardiac Amyloidosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108569/
https://www.ncbi.nlm.nih.gov/pubmed/35779241
http://dx.doi.org/10.1002/ejhf.2606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108569/
https://www.ncbi.nlm.nih.gov/pubmed/35779241
http://dx.doi.org/10.1002/ejhf.2606

Ejemplares similares